Liquid Biopsy clinical trials at University of California Health
1 research study open to eligible people
open to eligible people ages 18-80
The purpose of this study is to evaluate the safety and efficacy of targeted blood brain barrier disruption with Exablate Model 4000 Type 2.0/2.1 for liquid biopsy in subjects with suspected Glioblastoma brain tumors
Our lead scientists for Liquid Biopsy research studies include John de Groot, M.D..